XML 21 R11.htm IDEA: XBRL DOCUMENT
v3.25.3

Earnings per Share | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings per Share [Abstract] |
Earnings per Share | Note 3 - Earnings per Share The following table sets forth the computation of earnings per share.
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Net income applicable to common stock |  | $ | 10,005,000 |  |  | $ | 7,536,000 |  |  | $ | 26,089,000 |  |  | $ | 19,835,000 |
Basic earnings per share computation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted average common shares outstanding |  |  | 4,796,946 |  |  |  | 4,796,752 |  |  |  | 4,797,335 |  |  |  | 4,796,061 |
Earnings per share - basic |  | $ | 2.09 |  |  | $ | 1.57 |  |  | $ | 5.44 |  |  | $ | 4.14 |
Diluted earnings per share computation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted average common shares outstanding for basic earnings per share |  |  | 4,796,946 |  |  |  | 4,796,752 |  |  |  | 4,797,335 |  |  |  | 4,796,061 |
Add: Dilutive effects of restricted stock |  |  | 1,105 |  |  |  | 1,545 |  |  |  | 2,131 |  |  |  | 4,939 |
Weighted average common shares outstanding for dilutive earnings per share |  |  | 4,798,051 |  |  |  | 4,798,297 |  |  |  | 4,799,466 |  |  |  | 4,801,000 |
Earnings per share - diluted |  | $ | 2.09 |  |  | $ | 1.57 |  |  | $ | 5.44 |  |  | $ | 4.13 |
For the three months ended September 30, 2025 and 2024, there were 1,372 and 3,025 shares, respectively, related to the restricted stock plan that were excluded from the diluted earnings per share calculations since they were anti-dilutive. These anti-dilutive shares had per share prices ranging from $61.98-$83.38 for the three month period ended September 30, 2025 and per share prices ranging from $60.16-$83.38 for the three month period ended September 30, 2024. For the nine months ended September 30, 2025 and 2024, 1,372 and 3,025 shares, respectively, related to the restricted stock plan were excluded from the diluted earnings per share calculations since they were anti-dilutive. These anti-dilutive shares had prices ranging from $61.98-$83.38 for the nine month period ended September 30, 2025 and prices ranging from $60.16-$83.38 for the nine month period ended September 30, 2024.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration